TABLE 1.
Bacterial strain, plasmid, or primer | Description or sequencea | Sourceb |
---|---|---|
Strains | ||
G1222 | S. dysenteriae serotype 7 type strain | IMVS |
G1112 | E. coli O7 type strain | NICPBP |
E. coli BL21(DE3) | F−ompT hsdSB(rB− mB−) gal dcm (DE3) | Novagen |
E. coli DH5α | F− φ80lacZΔM15 endA recA1 hsdR(rK− mK−) supE44 thi-1 gyrA96 relA1 (lacZYA-argF)U169 | TBC |
Plasmids | ||
pET28a+ | T7 expression vector, Kanr | Novagen |
pLW1048 | pET28a+ containing N-terminally six-histidine-tagged rmlAD7 at the EcoRI/XhoI site | This work |
pLW1051 | pET28a+ containing C-terminally six-histidine-tagged rmlBD7 at the NcoI/XhoI site | This work |
pLW1049 | pET28a+ containing N-terminally six-histidine-tagged vioAD7 at the EcoRI/XhoI site | This work |
pLW1195 | pET28a+ containing N-terminally six-histidine-tagged vioAO7 at the BamHI/HindIII site | This work |
pLW1155 | pET28a+ containing C-terminally six-histidine-tagged vioBO7 at the NcoI/SalI site | This work |
Primers | AuGCT | |
wl-4235 (rmlA-D7F) | 5′-TAGAATTCATGGCTTACTCAGCAGTATG-3′ | |
wl-4236 (rmlA-D7R) | 5′-TTGGCTCTCGAGTTATTTGTCCTTAAC-3′ | |
wl-4241 (rmlB-D7F) | 5′-GCAGCCATGGAAATCCTTATTACAG-3′ | |
wl-4242 (rmlB-D7R) | 5′-GTCCTCGAGTTTCATTTCTCCATACTG-3′ | |
wl-4243 (vioA-D7F) | 5′-GAGAATTCATGGAAAAGCCAATCTTTGTAAC-3′ | |
wl-4244 (vioA-D7R) | 5′-GCACTTCTCGAGTCATTTAATCTCCCTAATC-3′ | |
wl-5702 (vioA-O7F) | 5′-GCAGGATCCATGAACGATAAAACTATTCCAGTAAC-3′ | |
wl-5703 (vioA-O7R) | 5′-GTCGAAGCTTTCACATCTTACCCAATAATAATTTG-3′ | |
wl-4704 (vioB-O7F) | 5′-GGTCCCATGGCCTATTTAGATGAAATAC-3′ | |
wl-4705 (vioB-O7R) | 5′-CGGAAGTCGACCAGATTATCTCCAATAG-3′ |
The underlined sequences indicate restriction sites.
IMVS, the Institute of Medical and Veterinary Science, Adelaide, Australia; NICPBP, the National Institute for the Control of Pharmaceutical and Biological Products, Beijing, China; TBC, Tianjin Biochip Corporation, Tianjin, China; AuGCT, AuGCT Biotechnology Corporation, Beijing, China.